Shandong Weigao Blood Purification Products Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Cunming Zhang

Chief executive officer

CN¥1.7m

Total compensation

CEO salary percentage	100.00%
CEO tenure	4.4yrs
CEO ownership	n/a
Management average tenure	3.6yrs
Board average tenure	3yrs

Recent management updates

No updates

Recent updates

No updates

CEO

Cunming Zhang (48 yo)

4.4yrs

Tenure

CN¥1,745,700

Compensation

Mr. Cunming Zhang is GM & Director of Shandong Weigao Blood Purification Products Co. Ltd. from December 2020.

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Cunming Zhang	GM & Director	4.4yrs	CN¥1.75m	no data
Jingang Zhang	Chief Financial Officer	3.6yrs	CN¥644.20k	no data
Xiaoyun Chen	Deputy GM & Director	3.6yrs	CN¥1.28m	no data
Ji Wang	Deputy GM & Director	3yrs	CN¥1.18m	no data
Changjun Mou	Deputy GM & Director	3yrs	CN¥1.35m	no data
Tingting Wang	Board Secretary	4.4yrs	CN¥866.50k	no data
Qian Li	Employee Supervisor & Deputy Manager of Financial Department	no data	no data	no data

3.6yrs

Average Tenure

48yo

Average Age

Experienced Management: 603014's management team is considered experienced (3.6 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Cunming Zhang	GM & Director	4.4yrs	CN¥1.75m	no data
Xiaoyun Chen	Deputy GM & Director	3.6yrs	CN¥1.28m	no data
Ji Wang	Deputy GM & Director	3yrs	CN¥1.18m	no data
Changjun Mou	Deputy GM & Director	3yrs	CN¥1.35m	no data
Qian Li	Employee Supervisor & Deputy Manager of Financial Department	1.4yrs	no data	no data
Xiushan Song	Chairman of the Board	4.4yrs	CN¥2.03m	no data
Zhengpeng Tang	Director	4.4yrs	no data	no data
Dapeng Song	Chairman of the Supervisory Board	4.4yrs	no data	no data
Erfei Liu	Independent Director	3yrs	CN¥228.10k	no data
Feng Zhou	Independent Director	1.4yrs	CN¥150.00k	no data
Senquan Zhang	Independent Director	3yrs	CN¥228.10k	no data
Bin Jiang	Member of Supervisory Board	1.4yrs	no data	no data

3.0yrs

Average Tenure

47.5yo

Average Age

Experienced Board: 603014's board of directors are considered experienced (3 years average tenure).

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/16 11:25
End of Day Share Price	2025/05/16 00:00
Earnings	2023/12/31
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Shandong Weigao Blood Purification Products Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.